LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.14 | 84.90 | 1761 | 3682 | 0.4783 | 0.7464 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.14 | 84.90 | 1807 | 3682 | 0.4908 | 0.7547 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.84 | 84.90 | 143 | 4003 | 0.0357 | 0.0983 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.84 | 84.90 | 1851 | 4003 | 0.4624 | 0.7409 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.84 | 84.90 | 1826 | 4003 | 0.4561 | 0.7366 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.84 | 84.90 | 1866 | 4003 | 0.4661 | 0.7434 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.55 | 84.90 | 155 | 4287 | 0.0361 | 0.1123 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.55 | 84.90 | 1886 | 4287 | 0.4398 | 0.7298 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.55 | 84.90 | 1915 | 4287 | 0.4466 | 0.7345 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 43.55 | 84.90 | 1970 | 4287 | 0.4594 | 0.7432 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.25 | 84.90 | 180 | 4539 | 0.0396 | 0.1399 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.25 | 84.90 | 2011 | 4539 | 0.4430 | 0.7355 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.25 | 84.90 | 2003 | 4539 | 0.4412 | 0.7343 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 45.25 | 84.90 | 2048 | 4539 | 0.4511 | 0.7410 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.95 | 84.90 | 199 | 4952 | 0.0402 | 0.1563 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.95 | 84.90 | 2102 | 4952 | 0.4244 | 0.7282 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.95 | 84.90 | 2077 | 4952 | 0.4194 | 0.7246 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.95 | 84.90 | 2120 | 4952 | 0.4281 | 0.7307 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.65 | 84.90 | 194 | 5328 | 0.0364 | 0.1484 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.65 | 84.90 | 2168 | 5328 | 0.4068 | 0.7204 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.65 | 84.90 | 2178 | 5328 | 0.4087 | 0.7217 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.65 | 84.90 | 2223 | 5328 | 0.4172 | 0.7276 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.36 | 84.90 | 213 | 5651 | 0.0377 | 0.1640 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.36 | 84.90 | 2289 | 5651 | 0.4051 | 0.7228 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.36 | 84.90 | 2324 | 5651 | 0.4113 | 0.7271 | MN20160318_Q02 | F04 |